financetom
Business
financetom
/
Business
/
EHang Partners With Weihai for Pilotless eVTOL Expansion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EHang Partners With Weihai for Pilotless eVTOL Expansion
Dec 27, 2024 6:25 AM

09:12 AM EST, 12/27/2024 (MT Newswires) -- EHang Holdings ( EH ) said Friday it signed an agreement with the city of Weihai in China's Shandong Province to set up a pilotless passenger eVTOL research and manufacturing base in Shandong and develop a low-altitude economy industrial park.

The partnership includes the purchase of a first batch of 30 EH216-S eVTOLs, EHang ( EH ) said, adding that Weihai completed full payment for the order.

Shares were up 3.2% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alaska Air, Hawaiian further extend review period of proposed deal
Alaska Air, Hawaiian further extend review period of proposed deal
Aug 15, 2024
(Reuters) - Alaska Air ( ALK ) said on Thursday it has agreed to further extend the review period of its proposed $1.9 billion acquisition of peer Hawaiian Holdings ( HA ) with the U.S. Department of Justice (DOJ). The companies will extend the review period with the DOJ until 12:01 AM ET, Aug 20. On Wednesday, the airlines had...
Top Premarket Gainers
Top Premarket Gainers
Aug 15, 2024
07:44 AM EDT, 08/15/2024 (MT Newswires) -- Airship AI (AISP) shares were up over 27% pre-bell Thursday after the company said it expects triple-digit revenue growth and positive cash flow for fiscal 2024. TIM (TIMB) stock was 15% higher following a 1% gain in the previous session. Lumentum Holdings ( LITE ) shares were up more than 14% after the...
Cellebrite's Q2 Adjusted Earnings, Revenue Increase; 2024 Outlook Raised
Cellebrite's Q2 Adjusted Earnings, Revenue Increase; 2024 Outlook Raised
Aug 15, 2024
07:41 AM EDT, 08/15/2024 (MT Newswires) -- Cellebrite DI ( CLBT ) reported Q2 adjusted earnings Thursday of $0.10 per diluted share, up from $0.05 a year earlier. Analysts surveyed by Capital IQ expected $0.05. Revenue for the quarter ended June 30 was $95.7 million, compared with $76.7 million a year earlier. Analysts polled by Capital IQ expected $91.9 million....
KalVista Secures EMA Validation of Marketing Authorization Application for Hereditary Angioedema Treatment
KalVista Secures EMA Validation of Marketing Authorization Application for Hereditary Angioedema Treatment
Aug 15, 2024
07:42 AM EDT, 08/15/2024 (MT Newswires) -- KalVista Pharmaceuticals ( KALV ) said Thursday that the European Medicines Agency has validated its marketing authorization application for sebetralstat, an oral plasma kallikrein inhibitor designed for the on-demand treatment of hereditary angioedema. The application, submitted in July, will next undergo review by the EMA's Committee for Medicinal Products for Human Use through...
Copyright 2023-2026 - www.financetom.com All Rights Reserved